UF Scientist’s Parkinson’s Work Selected for Innovative Drug Development Effort
University of Florida chemist Matthew Disney, Ph.D., was selected for an ambitious two-year effort to move promising Parkinson’s disease discoveries to patients.
First ‘Institute Professor’ of The Wertheim UF Scripps Institute Inventing New Ways to Target Incurable Diseases Via RNA
Matthew D. Disney, Ph.D., a professor and chair of the Department of Chemistry at The Wertheim UF Scripps Institute for Biomedical Innovation & Technology, has been named the first “Institute Professor” at the institution.
